Spyre Therapeutics
SYRE
SYRE
92 hedge funds and large institutions have $319M invested in Spyre Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 94 → 92 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $551K
Holders
92
Holding in Top 10
3
Calls
$2K
Puts
$551K
Top Buyers
| 1 | +$23M | |
| 2 | +$10.9M | |
| 3 | +$3.19M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$1.81M |
| 5 |
BlackRock
New York
|
+$883K |
Top Sellers
| 1 | -$9.04M | |
| 2 | -$7.63M | |
| 3 | -$2.66M | |
| 4 |
Renaissance Technologies
New York
|
-$2.34M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$985K |